vs
Side-by-side financial comparison of Bank First Corp (BFC) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
Viridian Therapeutics, Inc.\DE is the larger business by last-quarter revenue ($70.6M vs $44.9M, roughly 1.6× Bank First Corp). Bank First Corp runs the higher net margin — 45.8% vs -49.0%, a 94.8% gap on every dollar of revenue. On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs 12.1%). Bank First Corp produced more free cash flow last quarter ($51.0M vs $-84.7M).
First Horizon Corporation, formerly First Tennessee Bank, is a financial services company, founded in 1864, and based in Memphis, Tennessee. Through its banking subsidiary First Horizon Bank, it provides financial services through locations in 12 states across the Southeast, a region in which it is the fourth largest regional bank.
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
BFC vs VRDN — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $70.6M |
| Net Profit | $18.4M | $-34.6M |
| Gross Margin | — | — |
| Operating Margin | 51.0% | -56.7% |
| Net Margin | 45.8% | -49.0% |
| Revenue YoY | 12.1% | 81958.1% |
| Net Profit YoY | 4.8% | 54.9% |
| EPS (diluted) | $1.87 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | — | ||
| Q3 25 | $44.2M | $70.6M | ||
| Q2 25 | $41.6M | — | ||
| Q1 25 | $43.1M | — | ||
| Q4 24 | $40.1M | — | ||
| Q3 24 | $40.8M | — | ||
| Q2 24 | $38.9M | — | ||
| Q1 24 | $37.7M | — |
| Q4 25 | $18.4M | — | ||
| Q3 25 | $18.0M | $-34.6M | ||
| Q2 25 | $16.9M | — | ||
| Q1 25 | $18.2M | — | ||
| Q4 24 | $17.5M | — | ||
| Q3 24 | $16.6M | — | ||
| Q2 24 | $16.1M | — | ||
| Q1 24 | $15.4M | — |
| Q4 25 | 51.0% | — | ||
| Q3 25 | 50.8% | -56.7% | ||
| Q2 25 | 49.7% | — | ||
| Q1 25 | 51.3% | — | ||
| Q4 24 | 54.4% | — | ||
| Q3 24 | 50.7% | — | ||
| Q2 24 | 51.0% | — | ||
| Q1 24 | 45.6% | — |
| Q4 25 | 45.8% | — | ||
| Q3 25 | 40.7% | -49.0% | ||
| Q2 25 | 40.5% | — | ||
| Q1 25 | 42.3% | — | ||
| Q4 24 | 49.3% | — | ||
| Q3 24 | 40.6% | — | ||
| Q2 24 | 41.3% | — | ||
| Q1 24 | 40.8% | — |
| Q4 25 | $1.87 | — | ||
| Q3 25 | $1.83 | — | ||
| Q2 25 | $1.71 | — | ||
| Q1 25 | $1.82 | — | ||
| Q4 24 | $1.75 | — | ||
| Q3 24 | $1.65 | — | ||
| Q2 24 | $1.59 | — | ||
| Q1 24 | $1.51 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $243.2M | $490.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $643.8M | $503.0M |
| Total Assets | $4.5B | $577.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $243.2M | — | ||
| Q3 25 | $126.2M | $490.9M | ||
| Q2 25 | $120.3M | — | ||
| Q1 25 | $300.9M | — | ||
| Q4 24 | $261.3M | — | ||
| Q3 24 | $204.4M | — | ||
| Q2 24 | $99.0M | — | ||
| Q1 24 | $83.4M | — |
| Q4 25 | $643.8M | — | ||
| Q3 25 | $628.1M | $503.0M | ||
| Q2 25 | $612.3M | — | ||
| Q1 25 | $648.4M | — | ||
| Q4 24 | $639.7M | — | ||
| Q3 24 | $628.9M | — | ||
| Q2 24 | $614.6M | — | ||
| Q1 24 | $609.3M | — |
| Q4 25 | $4.5B | — | ||
| Q3 25 | $4.4B | $577.1M | ||
| Q2 25 | $4.4B | — | ||
| Q1 25 | $4.5B | — | ||
| Q4 24 | $4.5B | — | ||
| Q3 24 | $4.3B | — | ||
| Q2 24 | $4.1B | — | ||
| Q1 24 | $4.1B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $62.5M | $-84.6M |
| Free Cash FlowOCF − Capex | $51.0M | $-84.7M |
| FCF MarginFCF / Revenue | 113.6% | -120.1% |
| Capex IntensityCapex / Revenue | 25.5% | 0.2% |
| Cash ConversionOCF / Net Profit | 3.40× | — |
| TTM Free Cash FlowTrailing 4 quarters | $75.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $62.5M | — | ||
| Q3 25 | $15.5M | $-84.6M | ||
| Q2 25 | $11.9M | — | ||
| Q1 25 | $6.2M | — | ||
| Q4 24 | $65.8M | — | ||
| Q3 24 | $18.8M | — | ||
| Q2 24 | $14.9M | — | ||
| Q1 24 | $1.3M | — |
| Q4 25 | $51.0M | — | ||
| Q3 25 | $12.5M | $-84.7M | ||
| Q2 25 | $8.2M | — | ||
| Q1 25 | $4.0M | — | ||
| Q4 24 | $58.6M | — | ||
| Q3 24 | $16.9M | — | ||
| Q2 24 | $13.7M | — | ||
| Q1 24 | $551.0K | — |
| Q4 25 | 113.6% | — | ||
| Q3 25 | 28.2% | -120.1% | ||
| Q2 25 | 19.8% | — | ||
| Q1 25 | 9.3% | — | ||
| Q4 24 | 146.3% | — | ||
| Q3 24 | 41.5% | — | ||
| Q2 24 | 35.3% | — | ||
| Q1 24 | 1.5% | — |
| Q4 25 | 25.5% | — | ||
| Q3 25 | 6.7% | 0.2% | ||
| Q2 25 | 8.7% | — | ||
| Q1 25 | 5.0% | — | ||
| Q4 24 | 18.0% | — | ||
| Q3 24 | 4.5% | — | ||
| Q2 24 | 3.1% | — | ||
| Q1 24 | 2.1% | — |
| Q4 25 | 3.40× | — | ||
| Q3 25 | 0.86× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.34× | — | ||
| Q4 24 | 3.75× | — | ||
| Q3 24 | 1.13× | — | ||
| Q2 24 | 0.93× | — | ||
| Q1 24 | 0.09× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
